Literature DB >> 11359387

Cream psoralen plus ultraviolet A therapy for granuloma annulare.

M Grundmann-Kollmann1, F R Ochsendorf, T M Zollner, I Tegeder, R Kaufmann, M Podda.   

Abstract

BACKGROUND: Treatment modalities for granuloma annulare (GA) often remain unsatisfactory or can be accompanied by potentially hazardous side-effects. Psoralen plus ultraviolet (UV) A (PUVA) bath photochemotherapy has been reported to be highly effective in the treatment of GA. Another form of topical PUVA therapy, using 8-methoxypsoralen-containing cream or gel preparations, has been proven to be as effective as bath PUVA therapy in the treatment of palmoplantar dermatoses.
OBJECTIVES: To assess the efficacy of cream PUVA photochemotherapy in patients with GA.
METHODS: Five patients with GA were treated. The diagnosis was confirmed by pretreatment skin biopsies. Cream PUVA therapy was performed four times a week: the mean number of treatments was 26 (range 17-40) and mean cumulative UVA dose was 55.9 J cm-2 (range 18.2-109.2).
RESULTS: Cream PUVA photochemotherapy induced significant clinical improvement (one patient) or clearance (four patients) of GA in all patients. Clearance was documented clinically and histopathologically.
CONCLUSIONS: Cream PUVA phototherapy can be highly effective in patients affected by localized forms of GA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359387     DOI: 10.1046/j.1365-2133.2001.04188.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  [Granuloma annulare].

Authors:  L Kowalzick
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

2.  Granuloma annulare - remission with PUVASOL.

Authors:  Chembolli Lakshmi; C R Srinivas
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

3.  Granuloma annulare treated with excimer laser.

Authors:  Roman Bronfenbrener; Jennifer Ragi; Sandy Milgraum
Journal:  J Clin Aesthet Dermatol       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.